Effect of Switching from Cilnidipine to Azelnidipine on Cardiac Sympathetic Nerve Function in Patients with Heart Failure Preserved Ejection Fraction
Author:
Affiliation:
1. Department of Cardiovascular Medicine, Toho University Faculty of Medicine
Publisher
International Heart Journal (Japanese Heart Journal)
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Link
https://www.jstage.jst.go.jp/article/ihj/59/1/59_17-024/_pdf
Reference29 articles.
1. 1. Nitta D, Kinugawa K, Imamura T, Kato NP, Komuro I. High dose β-blocker therapy triggers additional reverse remodeling in patients with idiopathic non-ischemic cardiomyopathy. Int Heart J 2016; 57: 717-24.
2. 2. Ahn SA, Jong P, Yusuf S, Bangdiwala SI, Pouleur HG, Rousseau MF. Early versus delayed enalapril in patients with left ventricular systolic dysfunction: impact on morbidity and mortality 15 years after the SOLVD trial. J Am Coll Cardiol 2006; 47: 1904-5.
3. 3. Ohsaka T, Inomata T, Naruke T, et al. Clinical impact of adherence to guidelines on the outcome of chronic heart failure in Japan. Int Heart J 2008; 49: 59-73.
4. 4. Catterall WA, Striessnig J. Receptor sites for Ca2+ channel antagonists. Trends Pharmacol Sci 1992; 13: 256-62.
5. 5. Kimura Y, Hirooka Y, Sagara Y, Sunagawa K. Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity. Clin Exp Hypertens 2007; 29: 13-21.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prognostic impact of abnormal sodium burden in heart failure patients with preserved ejection fraction;European Journal of Clinical Investigation;2023-10-25
2. Therapeutic Usefulness of a Novel Calcium Channel Blocker Azelnidipine in the Treatment of Hypertension: A Narrative Review;Cardiology and Therapy;2022-08-13
3. Early initiation of tolvaptan is associated with early discharge in patients with heart failure regardless of age;BMC Cardiovascular Disorders;2022-04-29
4. Differential impact of antihypertensive drugs on cardiovascular remodeling: a review of findings and perspectives for HFpEF prevention;Hypertension Research;2021-10-08
5. Sympatho-adrenergic mechanisms in heart failure: new insights into pathophysiology;Medical Review;2021-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3